ReviewJournal of immunology research2015

Safety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant Recipients.

J R Bank et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.